Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment Mengqi SuYilin HouCong Chen Article Open access 27 February 2024 Pages: 850 - 863
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank Qiao JinEric S. H. Lauon behalf of the Hong Kong Diabetes Biobank Study Group Article Open access 27 February 2024 Pages: 837 - 849
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Rosa M. Sánchez-HernándezAna M. Wägner Letter 26 February 2024 Pages: 952 - 953
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes Alexandra Coomans de BrachèneMaria Ines AlvelosDecio L. Eizirik Extended Article 26 February 2024 Pages: 908 - 927
Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people Carolin T. LehnerMarian EberlStefanie J. Klug Article Open access 26 February 2024 Pages: 1040 - 1050
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study Jonne G. ter BraakeKelly J. Fleetwoodon behalf of the Scottish Diabetes Research Network Epidemiology Group Article Open access 26 February 2024 Pages: 1029 - 1039
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research Jeremy Basset‑SagarminagaTineke van de WeijerVera Schrauwen‑Hinderling Correction 23 February 2024 Pages: 958 - 958
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study Jimmy CélindMaria BygdellJenny M. Kindblom Article Open access 22 February 2024 Pages: 874 - 884
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes Pedro CardosoKatie G. Youngon behalf of the MASTERMIND consortium Article Open access 22 February 2024 Pages: 822 - 836
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Sophie BéliardFlorian MourreRené Valéro Review Open access 20 February 2024 Pages: 974 - 984
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment Richard I. G. HoltClive S. CockramAndrea O. Y. Luk Review Open access 20 February 2024
Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits Jianxin ZhenYuqin GuSiyang Liu Article Open access 19 February 2024 Pages: 703 - 713
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study Roderick C. SliekerMagnus MünchJoline W. J. Beulens Article Open access 19 February 2024 Pages: 885 - 894
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial Heikki HyötySusanna KääriäinenMiguel Sanjuan Article Open access 19 February 2024 Pages: 811 - 821
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life Natascia VedovatoMaria V. SalgueroFrances M. Ashcroft Article Open access 17 February 2024 Pages: 940 - 951
Metabolomic and genetic architecture of gestational diabetes subtypes Kristen LeeAlan KuangWilliam L. Lowe Jr Article 17 February 2024 Pages: 895 - 907
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis Milena JancevTessa A. C. M. VissersThomas T. van Sloten Article Open access 16 February 2024 Pages: 798 - 810
The insulin resistant brain: impact on whole-body metabolism and body fat distribution Martin Heni Review Open access 16 February 2024
Feasibility of prevention of type 2 diabetes in low- and middle-income countries Andre P. KengneAmbady Ramachandran Review Open access 15 February 2024 Pages: 763 - 772
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data Pedro F. TeixeiraTadej BattelinoGun Forsander For Debate Open access 14 February 2024 Pages: 985 - 994
Keeping pace: the primary cilium as the conducting baton of the islet Olof Idevall-HagrenCeren Incedal NilssonGonzalo Sanchez Review Open access 14 February 2024 Pages: 773 - 782
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial Matthias BlüherJulio RosenstockAnita M. Hennige Correction Open access 13 February 2024 Pages: 758 - 758
A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes Mengqi GuoHan GuoShufa Li Article 13 February 2024 Pages: 623 - 640
Harnessing the power of proteomics in precision diabetes medicine Nigel KurganJeppe Kjærgaard LarsenAtul S. Deshmukh Review 12 February 2024 Pages: 783 - 797
Epidemiology of heart failure in diabetes: a disease in disguise Anna G. HoekElisa Dal CantoJoline W. J. Beulens Review Open access 09 February 2024 Pages: 574 - 601
Surveillance of the liver in type 2 diabetes: important but unfeasible? Sami QadriHannele Yki-Järvinen Review Open access 09 February 2024 Pages: 961 - 973
Editorial Expression of Concern: Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial Zatollah AsemiMaryam KaramaliAhmad Esmaillzadeh Editorial Expression of Concern 30 January 2024 Pages: 759 - 760
Morning exercise as fasted-state activity. Reply to Chacko E [letter] Caiwei TianChirag J. Patel Letter 25 January 2024 Pages: 757 - 757
QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts Rodrigue GarciaLinda C. Schröderon behalf of the SURDIAGENE and the Mini-Finland study groups Article 24 January 2024 Pages: 641 - 649
Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study John SamuelssonRebecka BertilssonKarin Åkesson Article Open access 22 January 2024 Pages: 679 - 689
Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study Peter J. RaubenheimerJoanna SkeltonNaomi S. Levitt Article Open access 19 January 2024 Pages: 494 - 505
Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns Mingwei ShaoDuo ChenGuijun Qin Article 18 January 2024 Pages: 738 - 754
Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium Margaretha M. VisserAstrid Van MuylderNick Verhaeghe Article 18 January 2024 Pages: 650 - 662
Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study Edward W. GreggHaiying Chenfor the Look AHEAD Research Group Article Open access 18 January 2024 Pages: 459 - 469
Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes Karoliina TuomelaMegan K. Levings Review 18 January 2024 Pages: 611 - 622
Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α Beibei LiuDi XieYingqun Huang Article Open access 13 January 2024 Pages: 724 - 737
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children Sara BruzzanitiErica PiemonteMario Galgani Article Open access 12 January 2024 Pages: 714 - 723
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes Sandra HummelSarah Rosenbergerfor the GPPAD and POInT Study Group Article Open access 12 January 2024 Pages: 670 - 678
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia Hamzah AlzubaidiVitor H. OliveiraJonathan E. Shaw Short Communication Open access 12 January 2024 Pages: 663 - 669
Correction to: Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia Judit Castillo‑ArmengolFlavia MarzettaBernard Thorens Correction Open access 11 January 2024 Pages: 403 - 403
NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function Sharon Baumel-AlterzonLiora S. KatzDonald K. Scott Article 11 January 2024 Pages: 547 - 560
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study Nikki C. C. WerkmanGema García-SáezCoen D. A. Stehouwer Article Open access 11 January 2024 Pages: 690 - 702
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy Roshan DhanapalaratnamTushar IssarArun V. Krishnan Short Communication 08 January 2024 Pages: 561 - 566
Remission of type 2 diabetes: always more questions, but enough answers for action Amy RothbergMichael LeanBlandine Laferrère Review Open access 08 January 2024 Pages: 602 - 610
Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018 Nolwenn RegnaultElodie LebretonEmmanuel Cosson Article Open access 05 January 2024 Pages: 516 - 527
Type 2 diabetes and succinate: unmasking an age-old molecule Sonia Fernández-VeledoAnna Marsal-BeltranJoan Vendrell Review Open access 05 January 2024 Pages: 430 - 442